Don Hutson
Footballguy
Several world-renowned immunologists believe that leronlimab might be a game changer for Covid. Literally not one credible source has said one negative thing about leronlimab. The only negative chatter has been from stock market people who specialize in shorting stocks. CYDY is an easy target for them since it is an OTC with a buffoon for a CEO. The bar for a drug to be considered useful against Covid is set incredibly low because the Covid drugs currently being pushed by the FDA only help marginally. Helping Covid sufferers marginally is leronlimab's floor. Leronlimab's ceiling is it being the drug of choice that people are going to fight to acquire.I just see a lot of talking coming from CYDY. And even the talking isn’t really making a dent in the negative slides. Maybe this is how it works in pharma stocks - as I mentioned I am a noob at this.
But something just isn’t sitting right with me. If they had just stuck with their HIV and cancer angles, I’m boning up all over this thing. But the Covid angle makes them look like they are grasping at straws and the other stuff is being pushed to the wayside by the buying public.
Just feels off to me. That’s all.